AVGR - Dividend announcements

Initial $7.5 Million Strategic InvestmentStrategic Partnership Opens Pathway to Access Greater China MarketStrengthened Balance Sheet and Three-Year Extension of Existing Debt TermsREDWOOD CITY, CA / ACCESSWIRE / March 6, 2024 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced a new strategic partnership with Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, "Zylox-Tonbridge"), a leading medical device company in the neuro- and peripheral-vascular interventional market in China.Based in Hangzhou, China and l

13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales GrowthREDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today reported results for the first quarter ended March 31, 2021.First Quarter and Recent Highlights Revenue increased 13% year-over-year to $2.6 million, reflecting commercial launch of the new Tigereye™ CTO-crossing device and strong Pantheris SV sales growthGross margin improved 13 percentage points year-over-year to 35%, driven by i